ADAR1 Capital Management, LLC, 10% Owner at InMed Pharmaceuticals Inc. (INM), bought 42,920 shares at $1.33 ($57K) on 2026-10-01, disclosed to the SEC on 2026-10-05.
Open-market purchase of $57k INM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.33 | 16,431 | $22K | 38.3% |
| 2 | $1.33 | 8,307 | $11K | 19.4% |
| 3 | $1.33 | 18,182 | $24K | 42.4% |
| Total | $1.33 avg | 42,920 | $57K | 100% |
| Filing → |
| INM | BUY | 2026-09-16 | $118K | — | Filing → |
| TENX | BUY | 2026-09-08 | $1.6M | — | Filing → |
| TENX | BUY | 2026-09-02 | $1.4M | — | Filing → |